跳至主要内容
临床试验/NCT06038695
NCT06038695撤回不适用

Ultrasound-based Imaging to Detect Early Changes of Hard and Soft Tissue Around Immediately Placed Implants With Volume-Stable Collagen Matrix Combined With rhPDGF-BB: Pilot Study

I-Ching Wang2 个研究点 分布在 1 个国家开始时间: 2025年5月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Change in from Baseline in Soft and Hard Tissue Thickness as assessed by ultrasound.

研究概览

简要总结

The goal of this study is to test a volume-stable collagen matrix in combination with recombinant human platelet-derived growth factor-BB, specifically in patients who have an immediate implant placement for teeth #5-#12.

The main question this study aims to answer is does the recombinant human platelet-derived growth factor-BB accelerate the formation of blood vessels and augment tissue volume around the immediate implant.

Participants will be asked to undergo immediate implant placement using volume-stable collagen matrix in combination with recombinant human platelet-derived growth factor-BB, as well as attend 11 study visits over the course of 1.25 years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-95
  • Has a single hopeless tooth in the maxillary esthetic zone (i.e., first premolar to first premolar, tooth #5-tooth #13)
  • Adequate oral hygiene (i.e., full-mouth bleeding score (FMBS) and full mouth plaque score (FMPS) of less than 25%)
  • Adequate tooth space to support an immediate implant placement (i.e., adequate mesiodistal space of greater than or equal to 6 mm and interocclusal space to support a non-occluding provisionalization).
  • Postextraction vertical bone defect of the buccal socket wall was less than or equal to 3mm

排除标准

  • patients taking long-term (more than 3 months) medications affecting bone metabolism
  • generalized untreated periodontitis with greater than of 30% of sites with greater than 5mm pocket depths and bleeding upon probing with a dental probe
  • medical contraindications for having a surgical procedure (i.e., ASA Status of III, patient with a severe systemic disease that is not life-threatening; ASA Status of IV, a patient with a severe systemic disease that is a constant threat to life).
  • history of radiotherapy in the head and neck region
  • heavy smoker (greater than 10 cigarettes per day)
  • pregnancy
  • gingival recession before extraction in relation to the contralateral tooth

结局指标

主要结局

Change in from Baseline in Soft and Hard Tissue Thickness as assessed by ultrasound.

时间窗: Multiple time points (i.e. 0, Immediately after implant placement, 1 week, 2 weeks, 4 weeks, 6 weeks, 12 weeks, 16 weeks, 24 weeks, and 48 weeks after immediate implant placement

Tissues will be measured in millimeters.

次要结局

未报告次要终点

研究者

发起方
I-Ching Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

I-Ching Wang

Clinical Assistant Professor

University of Iowa

研究点 (2)

Loading locations...

相似试验